Your browser doesn't support javascript.
Diabetic ketoacidosis incidence among children with new-onset type 1 diabetes in Poland and its association with COVID-19 outbreak-Two-year cross-sectional national observation by PolPeDiab Study Group.
Pietrzak, Iwona; Michalak, Arkadiusz; Seget, Sebastian; Bednarska, Maria; Ben-Skowronek, Iwona; Bossowski, Artur; Chobot, Agata; Dzygalo, Katarzyna; Glowinska-Olszewska, Barbara; Górnicka, Martyna; Horodnicka-Józwa, Anita; Jakubek-Kipa, Katarzyna; Jarosz-Chobot, Przemyslawa; Marcinkiewicz, Katarzyna; Mazur, Artur; Mysliwiec, Malgorzata; Nazim, Joanna; Niechcial, Elzbieta; Noczynska, Anna; Rusak, Ewa; Seifert, Monika; Skotarczyk-Kowalska, Elzbieta; Skowronek, Anna; Szypowska, Agnieszka; Wais, Paulina; Walczak, Mieczyslaw; Woloszyn-Durkiewicz, Anna; Wysocka-Mincewicz, Marta; Zubkiewicz-Kucharska, Agnieszka; Szadkowska, Agnieszka.
  • Pietrzak I; Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland.
  • Michalak A; Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland.
  • Seget S; Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
  • Bednarska M; Department of Children's Diabetology, Medical University of Silesia, Katowice, Poland.
  • Ben-Skowronek I; Department of Pediatrics, University Clinical Hospital in Opole, Opole, Poland.
  • Bossowski A; Department of Pediatric Endocrinology and Diabetology, Medical University in Lublin, Lublin, Poland.
  • Chobot A; Department of Pediatrics, Endocrinology and Diabetology with Cardiology Unit, Medical University of Bialystok, Bialystok, Poland.
  • Dzygalo K; Department of Pediatrics, University Clinical Hospital in Opole, Opole, Poland.
  • Glowinska-Olszewska B; Department of Pediatrics, Institute of Medical Sciences, University of Opole, Opole, Poland.
  • Górnicka M; Department of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
  • Horodnicka-Józwa A; Department of Pediatrics, Endocrinology and Diabetology with Cardiology Unit, Medical University of Bialystok, Bialystok, Poland.
  • Jakubek-Kipa K; Department of Endocrinology and Diabetology, Children's Memorial Health Institute, Warsaw, Poland.
  • Jarosz-Chobot P; Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Marcinkiewicz K; Department of Pediatrics, Pediatric Endocrinology and Diabetes, Medical College University of Rzeszów, Rzeszów, Poland.
  • Mazur A; Department of Children's Diabetology, Medical University of Silesia, Katowice, Poland.
  • Mysliwiec M; Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Nazim J; Department of Pediatrics, Pediatric Endocrinology and Diabetes, Medical College University of Rzeszów, Rzeszów, Poland.
  • Niechcial E; Department of Pediatrics, Diabetology and Endocrinology, Medical University of Gdansk, Gdansk, Poland.
  • Noczynska A; Department of Pediatric Endocrinology, Jagiellonian University Medical College, Faculty of Medicine, Institute of Pediatrics, Kraków, Poland.
  • Rusak E; Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences, Poznan, Poland.
  • Seifert M; Department of Pediatric Endocrinology and Diabetology, Wroclaw Medical University, Wroclaw, Poland.
  • Skotarczyk-Kowalska E; Department of Children's Diabetology, Medical University of Silesia, Katowice, Poland.
  • Skowronek A; Department of Pediatric Endocrinology and Diabetology, Wroclaw Medical University, Wroclaw, Poland.
  • Szypowska A; Department of Children Endocrinology and Diabetology, Regional Polyclinical Hospital, Kielce, Poland.
  • Wais P; Department of Pediatric Endocrinology and Diabetology, Medical University in Lublin, Lublin, Poland.
  • Walczak M; Department of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
  • Woloszyn-Durkiewicz A; Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences, Poznan, Poland.
  • Wysocka-Mincewicz M; Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Zubkiewicz-Kucharska A; Department of Pediatrics, Diabetology and Endocrinology, Medical University of Gdansk, Gdansk, Poland.
  • Szadkowska A; Department of Endocrinology and Diabetology, Children's Memorial Health Institute, Warsaw, Poland.
Pediatr Diabetes ; 23(7): 944-955, 2022 11.
Article in English | MEDLINE | ID: covidwho-1886708
ABSTRACT

BACKGROUND:

There are several observations that the onset of coronavirus 19 (COVID-19) pandemic was associated with an increase in the incidence of diabetic ketoacidosis (DKA). However, due to heterogeneity in study designs and country-specific healthcare policies, more national-level evidence is needed to provide generalizable conclusions.

OBJECTIVE:

To compare the rate of DKA in Polish children diagnosed with type 1 diabetes (T1D) between the first year of COVID-19 pandemic (15 March 2020 to 15 March 2021) and the preceding year (15 March 2019 to 15 March 2020).

METHODS:

Reference centers in 13 regions (covering ~88% of Polish children) retrospectively reported all new-onset T1D cases in children from assessed periods, including DKA status at admission, administered procedures and outcomes. Secondly, we collected regions' demographic characteristics and the daily-reported number of COVID-19-related deaths in each region.

RESULTS:

We recorded 3062 cases of new-onset T1D (53.3% boys, mean age 9.5 ± 4.3 years old) of which 1347 (44%) had DKA. Comparing pre- and post-COVID-19 period, we observed a significant increase in the rate of DKA (37.5%-49.4%, p < .0001). The fraction of moderate (+5.4%) and severe (+3.4%) DKA cases increased significantly (p = .0089), and more episodes required assisted ventilation (+2.1%, p = .0337). Two episodes of DKA during 2020/2021 period were fatal. By region, change in DKA frequency correlated with initial COVID-19 death toll (March/April 2020) (R = .6, p = .0287) and change in T1D incidence (R = .7, p = .0080).

CONCLUSIONS:

The clinical picture of new-onset children T1D in Poland deteriorated over a 2-year period. The observed increase in the frequency of DKA and its severity were significantly associated with the overlapping timing of the COVID-19 epidemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Pediatr Diabetes Journal subject: Endocrinology Year: 2022 Document Type: Article Affiliation country: Pedi.13379

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Pediatr Diabetes Journal subject: Endocrinology Year: 2022 Document Type: Article Affiliation country: Pedi.13379